Loss of Transporter in Antigen Processing 1 Transport Protein and Major Histocompatibility Complex Class I Molecules in Metastatic versus Primary Breast Cancer

Cancer Research

Volumn 55, Issue 22, 1995, Pages 5191-5194

  Kaklamanis, Loukas ^a   Gatter, Kevin C ^a   Leek, Russell ^b   Koukourakis, Michael ^b   Harris, Adrian L ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CARRIER PROTEIN; HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL;

ATP-BINDING CASSETTE TRANSPORTERS; BETA 2-MICROGLOBULIN; BREAST NEOPLASMS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NEOPLASM METASTASIS;

EID: 0028789344     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Spies, T., Bresnahan, M., Bahrain, S., Arnold, D., Blanck, E., Mellins, E., Pious, D., and DcMars, R. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature (Lond.), 348: 744-747, 1990.
2. Darrow, T. L., Slingluff, C. L., and Seigler, H. F. The role of HLA class I antigens in recognition of melanoma cells by tumor specific cytotoxic T lymphocytes: evidence of shared tumor antigens. J. Immunol., 142: 3329-3335, 1989.
3. LeJeune, S., Leek, R., Horak, E., Plowman, G., Greenal, M., and Harris, A. L. Amphiregulin, epidermal growth factor receptor and estrogen receptor expression in human primary breast cancer. Cancer Res., 53: 3597-3602, 1993.
4. Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., McDonald, S., Pulford, K. A. F., and Mason, D. Y. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem., 32: 219-229, 1984.
5. Browning, M. J., Krausa, P., Rowan, A., Hill, A. B., Bicknell, D. C., Bodmer, J. G., and Bodmer, F. Loss of human leukocyte antigen expression on colorectal tumor cell lines: implications for anti-tumor immunity and immunotherapy. J. Immunother., 14: 163-168, 1993.
6. Concha, A., Esteban, F., Cabrera, T., Ruiz-Cabello, F., and Garrido, F. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin. Cancer Biol., 2: 47-54, 1991.
7. Wintzler, H. O., Benzing, M., and vonKleist, S. Lacking prognostic significance of 02-microglobulin, MHC class I and class II antigen expression in breast carcinomas. Br. J. Cancer, 62: 289-295, 1990.
8. Cromme, F. V., van Bommel, P. F. J., Walboomers, J. M. M., Gallee, M. P. W., Stern, P. L., Kenemans, P., Helmerhorst, Th. J. M., Stukart, M. J., and Meijer, C. J. L. M. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br. J. Cancer, 69: 1176-1181, 1994.
9. Sedlak, J., Speiser, P., Zeillinger, R., Krugluger, W., Wiltschke, C., Kubista, E., and Chorvath, B. Cytokine (IFN-a, IFN-y, IL-1 a, TNF-a) induced modulation of HLA cell surface expression in human breast cancer cell lines. Neoplasma (Bratisl.), 39: 269-272, 1992.
10. Jabrane-Ferrat, N., Faille, A., Loiseau, P., Poirier, O., Charron, D., and Calvo, F. Effect of y interferon on HLA class I and II transcription and protein expression in human breast adenocarcinoma cell lines. Int. J. Cancer, 45: 1169-1176, 1990.
11. Gardber, F. J., and Walker, R. A. Modulation of cell surface components of human breast cells by retinoic acid: enhanced HLA-DR expression. J. Pathol., 170: 23-29, 1993
12. Teh, M., and Hi, K. M. Modulation of MHC gene expression in human breast carcinoma cells by hormones. J. Immunogenet. (Oxf.), 16: 397-405, 1989.
13. Solary, E., Prud'Homme, J. F., Gauville, C., Magdelenat, H., and Calvo, F. Modulation of proliferation, estradiol receptors and estrogen regulated protein PS2/BCEI in human breast cancer cell lines by gamma interferon. J. Biol. Regul. Homeostatic Agents, 5: 98-106, 1991.
14. Nicolson, S., Wright, C., Sainsbury, R. C., Halcrow, P., Kelly, P., Angus, B., Farndon, R., and Harris, A. L. Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failure. J. Steroid. Biochem. Mol. Biol., 37: 811-814, 1990.
15. Versteeg, R., Noordermeer, I. A., Kruse-Wolters, M., Ruiter, D. J., and Schrier, P. I. c-myc down-regulates class I HLA expression in human melanomas. EMBO J., 7: 1023-1029, 1988.
16. Redondo, M., Ruiz-Cabello, F., Concha, A., Cabrera, T., Perez-Ayala, M., Oliva, M. R., and Garrida, F. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation. Cancer Res., 51: 2463-2468, 1991.
17. Denizot, F., Mattei, M. G., Vernet, C., Pontarotti, P., and Chimini, G. YAC-assisted cloning of a putative G-protein mapping to the MHC class I region. Genomics, 14: 857-862, 1992.
18. Nistico, P., De Barardinls, P., Morrone, S., Alonzi, T., Buono, C., Venturo, I., and Natali, P. G. Generation and characterization of two human a/0 T cell clones recognizing autologous breast tumor cells through HLA and TCR/CD3 independent pathways. J. Clin. Invest., 94: 1426-1431, 1994.